DOI QR코드

DOI QR Code

Anti-inflammatory Effect of Leaves Extracts from Aralia cordata through Inhibition of NF-κB and MAPKs Signaling in LPS-stimulated RAW264.7 Cells

  • Ji, Eo Hyun (Forest Medicinal Resources Research Center, National Institute of Forest Science) ;
  • Kim, Da Som (Forest Medicinal Resources Research Center, National Institute of Forest Science) ;
  • Sim, Su Jin (Forest Medicinal Resources Research Center, National Institute of Forest Science) ;
  • Park, Gwang Hun (Forest Medicinal Resources Research Center, National Institute of Forest Science) ;
  • Song, Jeong Ho (Forest Medicinal Resources Research Center, National Institute of Forest Science) ;
  • Jeong, Jin Boo (Department of Medicinal Plant Resources, Andong National University) ;
  • Kim, Nahyun (Forest Medicinal Resources Research Center, National Institute of Forest Science)
  • Received : 2018.11.07
  • Accepted : 2018.12.06
  • Published : 2018.12.31

Abstract

Aralia cordata (A. cordata), which belongs to Araliaceae, is a perennial herb widely distributed in East Asia. We evaluated the anti-inflammatory effect of stems (AC-S), roots (AC-R) and leaves (AC-L) extracted with 100% methanol of A. cordata and elucidated the potential signaling pathway in LPS-stimulated RAW264.7 cells. The AC-L showed a strong anti-inflammatory activity through inhibition of NO production. AC-L dose-dependently inhibited NO production by suppressing iNOS, COX-2 and $IL-{\beta}$ expression in LPS-stimulated RAW264.7 cells. AC-L inhibited the degradation and phosphorylation of $I{\kappa}B-{\alpha}$, which donated to the inhibition of p65 nuclear accumulation and $NF-{\kappa}B$ activation. Furthermore, AC-L suppressed the phosphorylation of ERK1/2 and p38. These results suggested that AC-L may utilize anti-inflammatory activity by blocking $NF-{\kappa}B$ and MAPK signaling pathway and indicated that the AC-L can be used as a natural anti-inflammatory drugs.

Keywords

JOSMBA_2018_v31n6_634_f0001.png 이미지

Fig. 1. Effect of the part of A. cordata on NO production in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were pretreated with AC-S, AC-R and AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 18 hours. The determination of NO production was measured by Griess assay. (B) RAW264.7 cells were treated with AC-L at the indicated concentrations for 24 hours. Cell viability was measured using MTT assay system and expressed as % cell viability. *P < 0.05 compared to the cells without the treatment, and #P < 0.05 compared to the cells treated with LPS alone.

JOSMBA_2018_v31n6_634_f0002.png 이미지

Fig. 2. The effect of AC-L on NO production and iNOS, COX-2 and IL-1β expression in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were pre-treated with AC-L at the indicated concentrations for 6 hours and then co-treated with LPS (1 ㎍/㎖) for the additional 18 hours. After treatment, NO production was measured using the media and Griess reagent and (B) cell lysates were resolved by SDS-PAGE, transferred to nitrocellulose membrane, and probed with iNOS and COX-2 antibody for Western blot. iNOS and COX-2 protein was visualized using ECL was used as a vehicle. (C) For RT-PCR, RAW264.7 cells were pre-treated with AC-L at the indicated concentrations for 6 hours and then co-treated with LPS (1 ㎍/㎖) for the additional 18 hours. Total RNA was isolated and RT-PCR was performed for iNOS and COX-2 and IL-1â. Values given are the mean ± SD (n = 3). *P < 0.05 compared to LPS treatment without AC-L. GAPDH was used as an internal control for RT-PCR.

JOSMBA_2018_v31n6_634_f0003.png 이미지

Fig. 3. The effect of AC-L on NF-κB signaling activation in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were pretreated with AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 20 minutes. (B) RAW264.7 cells were pretreated with AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 30 minutes. After the treatment, the cytosol and nucleus were prepared. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against Iκ B-α and p65. Actin was used as internal control.

JOSMBA_2018_v31n6_634_f0004.png 이미지

Fig. 4. The effect of AC-L on MAPK signaling activation in LPS-stimulated RAW264.7 cells. RAW264.7 cells were pretreated with AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 30 minutes. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against p-ERK1/2, p-p38 and Total p-38 and Total ERK1/2 were used as internal control.

References

  1. Bogdan, C. 2015. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 36:161-178. https://doi.org/10.1016/j.it.2015.01.003
  2. Chen, X., S.A. Tang, E. Lee, Y. Qiu, R. Wang, H.Q. Duan, S. Dan, M. Jin and D. Kong. 2015. IVSE, isolated from Inula japonica, suppresses LPS-induced NO production via NF-${\kappa}B$ and MAPK in activation in RAW264.7 cells. Life Sci. 124:8-15. https://doi.org/10.1016/j.lfs.2015.01.008
  3. Dolcet, X., D. Llobet, J. Pallares and X. Matias-Guiu. 2005. NF-${\kappa}B$ in development and progression of human cancer. Virchows Arch. 446:475-482. https://doi.org/10.1007/s00428-005-1264-9
  4. Gantke, T., S. Sriskantharajah, M. Sadowski and S.C. Ley. 2012. IkappaB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 246:168-182. https://doi.org/10.1111/j.1600-065X.2012.01104.x
  5. Gloire, G., S. Legrand-Poels and J. Piette. 2006. NF-${\kappa}B$ activation by reactive oxygenspecies: fifteen years later. Biochem Pharmacol. 72:1493-1505. https://doi.org/10.1016/j.bcp.2006.04.011
  6. Guzik, T.J., T. Korbut and T. Admek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54:469-487.
  7. Ha, S.K., E. Moon and S.Y. Kim. 2010. Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-${\kappa}B$ and JNK activations in microglia cells. Neurosci. Lett. 485:143-147. https://doi.org/10.1016/j.neulet.2010.08.064
  8. Kang, C.H., J.R. Koo and J.S. So. 2012. Inhibitory effects of Aralia cordata Thunb. extracts in nitric oxide synthesis in RAW264.7 macrophage cells. Korean J. Food Sci. Technol. 44:621-627. https://doi.org/10.9721/KJFST.2012.44.5.621
  9. Kim, H.N., S.B. Park, G.H. Park, H.J. Eo, J.H. Song, H.Y. Kwon and J.B. Jeong. 2018. Anti-inflammatory effect of the root extracts from Hibiscus syriacus in LPS-stimulated RAW264.7 cells. Korean J. Plant Res. 31:211-217.
  10. Lawrence, T. 2009. The Nuclear Factor NF-${\kappa}B$ Pathway in Inflammation. Cold Spring Harb Perspect Biol. 1:a001651.
  11. Lim, H., H.A. Jung, J.S. Choi, Y.S. Kim, S.S. Kang and H.P. Kim. 2009. Anti-inflammatory activity of the constituents of the roots of Aralia continentalis. Arch Pharm Res. 32:1237-1243. https://doi.org/10.1007/s12272-009-1909-3
  12. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064. https://doi.org/10.1096/fasebj.6.12.1381691
  13. Nishikori, M. 2005. Classical and alternative NF-${\kappa}B$ activation pathways and their roles in lymphoid malignancies. J. Clin. Exp. Hematopathol. 45:15-24. https://doi.org/10.3960/jslrt.45.15
  14. Park, G.H., J.H. Park, H.J. Eo, H.M. Song, M.H. Lee, J.R. Lee and J.B. Jeong. 2014. Anti-inflammatory effect of the extracts from Abeliophyllum distichum Nakai in LPS-stimulated RAW264.7 cells. Korean J. Plant Res. 27:209-214. https://doi.org/10.7732/kjpr.2014.27.3.209
  15. Sun, P., Zhou. K, S. Wang, P. Li, S. Chen, G. Lin, Y. Zhao and T. Wang. 2013. Involvement of MAPK/NF-${\kappa}B$ signaling in the activation of the cholinergic anti-Inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One 8:e69424. https://doi.org/10.1371/journal.pone.0069424
  16. Surh, Y.J., K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park and S.S. Lee. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Research 480-481:243-268. https://doi.org/10.1016/S0027-5107(01)00183-X
  17. Taniguchi, K. and M. Karin. 2018. NF-${\kappa}B$, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 18:309-324. https://doi.org/10.1038/nri.2017.142
  18. Tsuzaki, M., D. Bynum, L. Almekinders, X. Yang, J. Faber and A.J. Banes. 2003. ATP modulates load-inducible IL-1beta, COX 2, and MMP-3 gene expression in human tendon cells. J Cell Biochem. 1:556-562.
  19. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735. https://doi.org/10.1101/gad.9.22.2723
  20. Wang, D. and R.N. Dubois. 2010. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 9:781-788.
  21. Zarghi, A. and S. Arfaei. 2011. Selective COX-2 inhibitors: A review of their structure-activity relationships. Iran J Pharm Res. 10:655-683.

Cited by

  1. Anti-inflammatory effects of 18-nor-ent-pimara-9(11),15-diene-4β-ol isolated from the roots of Aralia continentalis on LPS-induced in RAW264.7 cells vol.63, pp.1, 2018, https://doi.org/10.1186/s13765-020-00553-7